Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

AUTORISERET FYSIOTERAPEUTSELSKAB KLINIK FOR FYSIOTERAPI NORDBORG ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.8% 0.8% 0.8% 0.8% 0.8% 0.8% 0.8% 0.8%   Bankruptcy risk   8.7% 7.5% 9.5% 8.5% 4.2% 4.1% 17.6% 17.3%   Credit score (0-100)   30 33 26 27 48 48 9 9   Credit rating   BB BB BB BB BBB BBB B BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   943 753 674 663 805 741 0.0 0.0   EBITDA   424 331 76.0 120 323 309 0.0 0.0   EBIT   218 182 -51.0 120 323 309 0.0 0.0   Pre-tax profit (PTP)   190.0 181.0 -55.0 116.0 325.0 321.6 0.0 0.0   Net earnings   194.0 141.0 -44.0 90.0 251.0 251.3 0.0 0.0   Pre-tax profit without non-rec. items   190 181 -55.0 116 325 322 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   81.0 222 177 268 518 470 170 170   Interest-bearing liabilities   291 170 92.0 264 231 171 0.0 0.0   Balance sheet total (assets)   429 507 344 574 859 740 170 170   Net Debt   262 164 -80.0 -8.0 -37.0 -195 -170 -170     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   943 753 674 663 805 741 0.0 0.0   Gross profit growth   -18.4% -20.1% -10.5% -1.6% 21.4% -8.0% -100.0% 0.0%   Employees   2 1 1 1 1 1 0 0   Employee growth %   0.0% -50.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   429 507 344 574 859 740 170 170   Balance sheet change%   -52.5% 18.2% -32.1% 66.9% 49.7% -13.8% -77.0% 0.0%   Added value   424.0 331.0 76.0 120.0 323.0 309.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -412 -298 -254 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 -1.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   23.1% 24.2% -7.6% 18.1% 40.1% 41.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   30.2% 41.2% -11.8% 26.1% 47.6% 42.2% 0.0% 0.0%   ROI %   32.4% 50.5% -15.1% 30.0% 53.2% 48.5% 0.0% 0.0%   ROE %   39.4% 93.1% -22.1% 40.4% 63.9% 50.9% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   18.9% 43.8% 51.5% 46.7% 60.3% 63.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   61.8% 49.5% -105.3% -6.7% -11.5% -62.9% 0.0% 0.0%   Gearing %   359.3% 76.6% 52.0% 98.5% 44.6% 36.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   19.2% 5.2% 3.8% 2.2% 6.5% 7.8% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.4 1.3 1.9 1.8 2.5 2.7 0.0 0.0   Current Ratio   0.4 1.3 1.9 1.8 2.5 2.7 0.0 0.0   Cash and cash equivalent   29.0 6.0 172.0 272.0 268.0 366.0 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -195.0 73.0 155.0 246.0 496.0 447.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   212 331 76 120 323 309 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   212 331 76 120 323 309 0 0   EBIT / employee   109 182 -51 120 323 309 0 0   Net earnings / employee   97 141 -44 90 251 251 0 0